Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of topical clobetasol on bone mineral density in bullous pemphigoid
2018-003953-46Phase 4Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clobetasol in Bullous Pemphigoid (BP), sponsored by CHU Amiens-Picardie. Primary endpoint: Change in lumbar spine bone mineral density at 6 months. Started Mar 2019; status: active.
02
Drugs
clobetasol
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on 2018-003953-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003953-46.